Impact of individual clinical outcomes on trial participants' perspectives on enrollment in emergency research without consent
- PMID: 28359192
- PMCID: PMC5380144
- DOI: 10.1177/1740774516677276
Impact of individual clinical outcomes on trial participants' perspectives on enrollment in emergency research without consent
Abstract
Background: Evidence suggests that patients are generally accepting of their enrollment in trials for emergency care conducted under exception from informed consent. It is unknown whether individuals with more severe initial injuries or worse clinical outcomes have different perspectives. Determining whether these differences exist may help to structure post-enrollment interactions.
Methods: Primary clinical data from the Progesterone for the Treatment of Traumatic Brain Injury trial were matched to interview data from the Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury study. Answers to three key questions from Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury study were analyzed in the context of enrolled patients' initial injury severity (initial Glasgow Coma Scale and Injury Severity Score) and principal clinical outcomes (Extended Glasgow Outcome Scale and Extended Glasgow Outcome Scale relative to initial injury severity). The three key questions from Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury study addressed participants' general attitude toward inclusion in the Progesterone for the Treatment of Traumatic Brain Injury trial (general trial inclusion), their specific attitude toward being included in Progesterone for the Treatment of Traumatic Brain Injury trial under the exception from informed consent (personal exception from informed consent enrollment), and their attitude toward the use of exception from informed consent in the Progesterone for the Treatment of Traumatic Brain Injury trial in general (general exception from informed consent enrollment). Qualitative analysis of interview transcripts was performed to provide contextualization and to determine the extent to which respondents framed their attitudes in terms of clinical experience.
Results: Clinical data from Progesterone for the Treatment of Traumatic Brain Injury trial were available for all 74 patients represented in the Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury study (including 46 patients for whom the surrogate was interviewed due to the patient's cognitive status or death). No significant difference was observed regarding acceptance of general trial inclusion or acceptance of general exception from informed consent enrollment between participants with favorable neurological outcomes and those with unfavorable outcomes relative to initial injury. Agreement with personal enrollment in Progesterone for the Treatment of Traumatic Brain Injury trial under exception from informed consent, however, was significantly higher among participants with favorable outcomes compared to those with unfavorable outcomes (89% vs 59%, p = 0.003). There was also a statistically significant relationship between more severe initial injury and increased acceptance of personal exception from informed consent enrollment ( p = 0.040) or general exception from informed consent use ( p = 0.034) in Progesterone for the Treatment of Traumatic Brain Injury trial. Many individuals referenced personal experience as a basis for their attitudes, but these references were not used to support negative views.
Conclusion: Patients and surrogates of patients with unfavorable clinical outcomes were somewhat less accepting of their own inclusion in the Progesterone for the Treatment of Traumatic Brain Injury trial under exception from informed consent than were patients or surrogates of patients with favorable clinical outcomes. These findings suggest a need to identify optimal strategies for communicating with patients and their surrogates regarding exception from informed consent enrollment when clinical outcomes are poor.
Keywords: Research ethics; acute care research; bioethics; emergency research; informed consent; traumatic brain injury.
Figures
Similar articles
-
Patients' perspectives of enrollment in research without consent: the patients' experiences in emergency research-progesterone for the treatment of traumatic brain injury study.Crit Care Med. 2015 Mar;43(3):603-12. doi: 10.1097/CCM.0000000000000747. Crit Care Med. 2015. PMID: 25574795 Free PMC article. Clinical Trial.
-
Does experience matter? Implications for community consultation for research in emergency settings.AJOB Empir Bioeth. 2017 Apr-Jun;8(2):75-81. doi: 10.1080/23294515.2017.1308978. Epub 2017 Mar 24. AJOB Empir Bioeth. 2017. PMID: 28949843
-
Patient and Surrogate Postenrollment Perspectives on Research Using the Exception From Informed Consent: An Integrated Survey.Ann Emerg Med. 2020 Sep;76(3):343-349. doi: 10.1016/j.annemergmed.2020.03.017. Epub 2020 May 21. Ann Emerg Med. 2020. PMID: 32446674
-
Another failed attempt of neuroprotection: progesterone for moderate and severe traumatic brain injury.Minerva Anestesiol. 2016 Apr;82(4):486-91. Epub 2015 Jul 1. Minerva Anestesiol. 2016. PMID: 26126980 Review.
-
Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury.J Neurotrauma. 2017 Jun 1;34(11):1915-1918. doi: 10.1089/neu.2015.4179. Epub 2016 Dec 13. J Neurotrauma. 2017. PMID: 26370183 Free PMC article. Review.
Cited by
-
Perspectives of ICU Patients on Deferred Consent in the Context of Post-ICU Quality of Life: A Substudy of a Randomized Clinical Trial.Crit Care Med. 2024 May 1;52(5):694-703. doi: 10.1097/CCM.0000000000006184. Epub 2024 Jan 5. Crit Care Med. 2024. PMID: 38180043 Free PMC article. Clinical Trial.
-
Adrenaline to improve survival in out-of-hospital cardiac arrest: the PARAMEDIC2 RCT.Health Technol Assess. 2021 Apr;25(25):1-166. doi: 10.3310/hta25250. Health Technol Assess. 2021. PMID: 33861194 Free PMC article. Clinical Trial.
-
Emergency Consent: Patients' and Surrogates' Perspectives on Consent for Clinical Trials in Acute Stroke and Myocardial Infarction.J Am Heart Assoc. 2019 Jan 22;8(2):e010905. doi: 10.1161/JAHA.118.010905. J Am Heart Assoc. 2019. PMID: 30663498 Free PMC article.
-
Detailed systematic analysis of recruitment strategies in randomised controlled trials in patients with an unscheduled admission to hospital.BMJ Open. 2018 Feb 2;8(2):e018581. doi: 10.1136/bmjopen-2017-018581. BMJ Open. 2018. PMID: 29420230 Free PMC article. Review.
-
Patient and surrogate attitudes via an interviewer-administered survey on exception from informed consent enrollment in the Prehospital Air Medical Plasma (PAMPer) trial.BMC Emerg Med. 2020 Oct 1;20(1):76. doi: 10.1186/s12873-020-00371-6. BMC Emerg Med. 2020. PMID: 33004018 Free PMC article. Clinical Trial.
References
-
- Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283:2701–2711. - PubMed
-
- Largent EA, Wendler D, Emanuel E, et al. Is emergency research without initial consent justified?: the consent substitute model. Arch Intern Med. 2010;170:668–674. - PubMed
-
- United States Department of Health and Human Services. Protection of Human Subjects. Washington, DC: 2009. Title 45 (Code of Federal Regulations), Part 46.
-
- United States Food and Drug Administration. Protection of Human Subjects. Silver Spring, MD: 2004. Title 21 (Code of Federal Regulations), Part 50.24.
-
- Potter JE, McKinley S, Delaney A. Research participants' opinions of delayed consent for a randomised controlled trial of glucose control in intensive care. Intensive Care Med. 2013;39:472–480. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical